Join Dr. Na Li as she explores the mysteries of the particle drifting effect and its practical applications in real-world ...

近 20 多年来，一系列的 CETP 抑制剂被研发出来，但在 Obicetrapib 之前，仅有 Torcetrapib、Dalcetrapib、Evacetrapib 及Anacetrapib等四个药物进入临床试验中进行了从安全性、血脂谱变化。以及是否能够获得心血管事件风险降低的临床获益的全面评估。 是第一个进入临床试验 ...

Clin Lipidology. 2014;9(1):101-118. TAUSSIG: a multicenter, open-label study to assess the long-term safety, tolerability, and efficacy of AMG145 on LDL-C in subjects with severe familial ...